Emory researchers are the first to show a new adjuvant, 3M-052, helps induce long-lasting immunity against HIV. This finding has implications for developing successful vaccines against HIV, influenza and COVID-19.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/06/200620141952.htm
No comments:
Post a Comment